Literature DB >> 26768074

Approaches of robot-assisted neck dissection for head and neck cancer: a review.

Shanghui Zhou1, Chenping Zhang2, Daqing Li3.   

Abstract

Robot-assisted surgery is being increasingly used by surgeons because of its enhancement of visualization, precision, and articulation compared with conventional minimally invasive techniques. In recent years, robot-assisted neck dissection (RAND) has begun to be used as an alternative method of neck dissection, one of the classic surgical procedures in the area of head and neck surgery. Currently, there are four kinds of approaches for RAND: (1) modified facelift or retroauricular incision, (2) combined transaxillary and retroauricular incision, (3) transaxillary incision, and (4) transoral incision. RAND may help perform minimally invasive surgery and achieve excellent cosmetic results as well as the desired oncologic outcomes, and this requires selecting an appropriate approach based on the different needs of neck dissections. Although experienced surgeons wishing to avoid large cervical incisions in patients can safely perform RAND, there are still quite a few limitations; in particular, surgical morbidity and oncologic outcomes should be verified by further prospective clinical trials with longer follow-up periods. Also, RAND needs to be standardized and its use disseminated. In this review, we introduce the applications of different approaches for RAND and their indications and determine whether RAND can be more beneficial compared with conventional surgeries.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26768074     DOI: 10.1016/j.oooo.2015.10.027

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  1 in total

1.  Selective Neck Dissection in Oral Cavity Cancer Is Not Without Morbidity.

Authors:  Adharsh Anand; Sivakumar Vidhyadharan; Narayana Subramaniam; Deepak Balsubramanian; Azhar Jan Battoo; Subramania Iyer; Krishnakumar Thankappan
Journal:  Indian J Surg Oncol       Date:  2020-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.